339 related articles for article (PubMed ID: 29518828)
1. [Clinical characteristics of human recombination activating gene 1 mutations in 8 immunodeficiency patients with diverse phenotypes].
Yu G; Wang WJ; Liu DR; Tao ZF; Hui XY; Hou J; Sun JQ; Wang XC
Zhonghua Er Ke Za Zhi; 2018 Mar; 56(3):186-191. PubMed ID: 29518828
[No Abstract] [Full Text] [Related]
2. Recombinase-activating gene 1 immunodeficiency: different immunological phenotypes in three siblings.
Pasic S; Djuricic S; Ristic G; Slavkovic B
Acta Paediatr; 2009 Jun; 98(6):1062-4. PubMed ID: 19243569
[TBL] [Abstract][Full Text] [Related]
3. From Severe Combined Immunodeficiency to Omenn syndrome after hematopoietic stem cell transplantation in a RAG1 deficient family.
Martinez-Martinez L; Vazquez-Ortiz M; Gonzalez-Santesteban C; Martin-Nalda A; Vicente A; Plaza AM; Badell I; Alsina L; de la Calle-Martin O
Pediatr Allergy Immunol; 2012 Nov; 23(7):660-6. PubMed ID: 22882342
[TBL] [Abstract][Full Text] [Related]
4. Novel mutatıons and diverse clinical phenotypes in recombinase-activating gene 1 deficiency.
Kutukculer N; Gulez N; Karaca NE; Aksu G; Berdeli A
Ital J Pediatr; 2012 Mar; 38():8. PubMed ID: 22424479
[TBL] [Abstract][Full Text] [Related]
5. A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection.
de Villartay JP; Lim A; Al-Mousa H; Dupont S; Déchanet-Merville J; Coumau-Gatbois E; Gougeon ML; Lemainque A; Eidenschenk C; Jouanguy E; Abel L; Casanova JL; Fischer A; Le Deist F
J Clin Invest; 2005 Nov; 115(11):3291-9. PubMed ID: 16276422
[TBL] [Abstract][Full Text] [Related]
6. Mutations in Recombination Activating Gene 1 and 2 in patients with severe combined immunodeficiency disorders in Egypt.
Meshaal S; El Hawary R; Elsharkawy M; Mousa RK; Farid RJ; Abd Elaziz D; Alkady R; Galal N; Massaad MJ; Boutros J; Elmarsafy A
Clin Immunol; 2015 Jun; 158(2):167-73. PubMed ID: 25869295
[TBL] [Abstract][Full Text] [Related]
7. A Large Cohort of RAG1/2-Deficient SCID Patients-Clinical, Immunological, and Prognostic Analysis.
Greenberg-Kushnir N; Lee YN; Simon AJ; Lev A; Marcus N; Abuzaitoun O; Somech R; Stauber T
J Clin Immunol; 2020 Jan; 40(1):211-222. PubMed ID: 31838659
[TBL] [Abstract][Full Text] [Related]
8. A novel homozygous
Melika S; Hossein E; Mona S; Elham R; Samaneh Z; Sepideh S; Raul Jimenez H; Ana K; Kaan B; Nima R
Allergol Immunopathol (Madr); 2021; 49(4):91-97. PubMed ID: 34224223
[TBL] [Abstract][Full Text] [Related]
9. Mutation c.256_257delAA in RAG1 Gene in Polish Children with Severe Combined Immunodeficiency: Diversity of Clinical Manifestations.
Szaflarska A; Rutkowska-Zapała M; Kotula M; Gruca A; Grabowska A; Lenart M; Surman M; Trzyna E; Mordel A; Pituch-Noworolska A; Siedlar M
Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):177-183. PubMed ID: 28083621
[TBL] [Abstract][Full Text] [Related]
10. Characterization of immune function and analysis of RAG gene mutations in Omenn syndrome and related disorders.
Wada T; Takei K; Kudo M; Shimura S; Kasahara Y; Koizumi S; Kawa-Ha K; Ishida Y; Imashuku S; Seki H; Yachie A
Clin Exp Immunol; 2000 Jan; 119(1):148-55. PubMed ID: 10606976
[TBL] [Abstract][Full Text] [Related]
11. [Clinical phenotype and gene diagnostic analysis of Omenn syndrome].
Wang YQ; Cui YX; Feng J
Zhonghua Er Ke Za Zhi; 2013 Jan; 51(1):64-8. PubMed ID: 23527934
[TBL] [Abstract][Full Text] [Related]
12. Recombination-activating gene 1 (Rag1)-deficient mice with severe combined immunodeficiency treated with lentiviral gene therapy demonstrate autoimmune Omenn-like syndrome.
van Til NP; Sarwari R; Visser TP; Hauer J; Lagresle-Peyrou C; van der Velden G; Malshetty V; Cortes P; Jollet A; Danos O; Cassani B; Zhang F; Thrasher AJ; Fontana E; Poliani PL; Cavazzana M; Verstegen MM; Villa A; Wagemaker G
J Allergy Clin Immunol; 2014 Apr; 133(4):1116-23. PubMed ID: 24332219
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and molecular analysis of three Chinese children with Omenn syndrome.
Zhang ZY; Zhao XD; Jiang LP; Liu EM; Cui YX; Wang M; Wei H; Yu J; An YF; Yang XQ
Pediatr Allergy Immunol; 2011 Aug; 22(5):482-7. PubMed ID: 21771083
[TBL] [Abstract][Full Text] [Related]
14. Detection of RAG mutations and prenatal diagnosis in families presenting with either T-B- severe combined immunodeficiency or Omenn's syndrome.
Tabori U; Mark Z; Amariglio N; Etzioni A; Golan H; Biloray B; Toren A; Rechavi G; Dalal I
Clin Genet; 2004 Apr; 65(4):322-6. PubMed ID: 15025726
[TBL] [Abstract][Full Text] [Related]
15. A systematic analysis of recombination activity and genotype-phenotype correlation in human recombination-activating gene 1 deficiency.
Lee YN; Frugoni F; Dobbs K; Walter JE; Giliani S; Gennery AR; Al-Herz W; Haddad E; LeDeist F; Bleesing JH; Henderson LA; Pai SY; Nelson RP; El-Ghoneimy DH; El-Feky RA; Reda SM; Hossny E; Soler-Palacin P; Fuleihan RL; Patel NC; Massaad MJ; Geha RS; Puck JM; Palma P; Cancrini C; Chen K; Vihinen M; Alt FW; Notarangelo LD
J Allergy Clin Immunol; 2014 Apr; 133(4):1099-108. PubMed ID: 24290284
[TBL] [Abstract][Full Text] [Related]
16. Highly variable clinical phenotypes of hypomorphic RAG1 mutations.
Avila EM; Uzel G; Hsu A; Milner JD; Turner ML; Pittaluga S; Freeman AF; Holland SM
Pediatrics; 2010 Nov; 126(5):e1248-52. PubMed ID: 20956421
[TBL] [Abstract][Full Text] [Related]
17. Similar recombination-activating gene (RAG) mutations result in similar immunobiological effects but in different clinical phenotypes.
IJspeert H; Driessen GJ; Moorhouse MJ; Hartwig NG; Wolska-Kusnierz B; Kalwak K; Pituch-Noworolska A; Kondratenko I; van Montfrans JM; Mejstrikova E; Lankester AC; Langerak AW; van Gent DC; Stubbs AP; van Dongen JJ; van der Burg M
J Allergy Clin Immunol; 2014 Apr; 133(4):1124-33. PubMed ID: 24418478
[TBL] [Abstract][Full Text] [Related]
18. Partial correction of immunodeficiency by lentiviral vector gene therapy in mouse models carrying
Castiello MC; Di Verniere M; Draghici E; Fontana E; Penna S; Sereni L; Zecchillo A; Minuta D; Uva P; Zahn M; Gil-Farina I; Annoni A; Iaia S; Ott de Bruin LM; Notarangelo LD; Pike-Overzet K; Staal FJT; Villa A; Capo V
Front Immunol; 2023; 14():1268620. PubMed ID: 38022635
[TBL] [Abstract][Full Text] [Related]
19. Immunological assessment of a patient with Omenn syndrome resulting from compound heterozygous mutations in the RAG1 gene.
Mou W; Yang Z; Wang X; Hei M; Wang Y; Gui J
Immunogenetics; 2023 Aug; 75(4):385-393. PubMed ID: 37269334
[TBL] [Abstract][Full Text] [Related]
20. Analysis of mutations and recombination activity in RAG-deficient patients.
Asai E; Wada T; Sakakibara Y; Toga A; Toma T; Shimizu T; Nampoothiri S; Imai K; Nonoyama S; Morio T; Muramatsu H; Kamachi Y; Ohara O; Yachie A
Clin Immunol; 2011 Feb; 138(2):172-7. PubMed ID: 21131235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
